LEADER 03335nam  22005655  450 
001 9910350350903321
005 20200629223032.0
010   $a981-13-8723-0
024 7 $a10.1007/978-981-13-8723-4
035   $a(CKB)4100000009158787
035   $a(MiAaPQ)EBC5847904
035   $a(DE-He213)978-981-13-8723-4
035   $a(PPN)248600478
035   $a(EXLCZ)994100000009158787
100   $a20190807d2019      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDevelopment of Novel Stability Indicating Methods Using Liquid Chromatography /$fby Mukesh Maithani, Parveen Bansal
205   $a1st ed. 2019.
210  1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2019.
215   $a1 online resource (xxii, 101 pages)
311   $a981-13-8722-2 
327   $aChapter 1. Introduction -- Chapter 2. Research Envisaged -- Chapter 3. Drug(s) Profile -- Chapter 4. Materials and Methods -- Chapter 5. Results and Discussion -- Chapter 6. Summary and Conclusion.-.
330   $aReversed-phase high-performance liquid chromatography (RP-HPLC) has become the most widely used method for pharmaceutical analysis, as it ensures accuracy, specificity and reproducibility for the quantification of drugs, while avoiding interference from any of the excipients that are normally present in pharmaceutical dosage forms. This book presents a simple methodology for developing stability-indicating methods and offers a ?how-to guide? to creating novel stability-indicating methods using liquid chromatography. It provides the detailed information needed to devise a stability-indicating method for drug substances and drug products that comply with international regulatory guidelines. As such, it is a must-read for anyone engaged in analytical and bioanalytical chemistry: professionals at reference, test, and control laboratories; students and academics at research laboratories, and scientists working for chemical, pharmaceutical, and biotechnology companies.
606   $aDiagnosis, Laboratory
606   $aPharmaceutical technology
606   $aChromatographic analysis
606   $aPharmacy
606   $aLaboratory Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B15007
606   $aPharmaceutical Sciences/Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21010
606   $aChromatography$3https://scigraph.springernature.com/ontologies/product-market-codes/C11030
606   $aPharmacy$3https://scigraph.springernature.com/ontologies/product-market-codes/F00008
615  0$aDiagnosis, Laboratory.
615  0$aPharmaceutical technology.
615  0$aChromatographic analysis.
615  0$aPharmacy.
615 14$aLaboratory Medicine.
615 24$aPharmaceutical Sciences/Technology.
615 24$aChromatography.
615 24$aPharmacy.
676   $a616.075
700   $aMaithani$b Mukesh$4aut$4http://id.loc.gov/vocabulary/relators/aut$0892735
702   $aBansal$b Parveen$4aut$4http://id.loc.gov/vocabulary/relators/aut
906   $aBOOK
912   $a9910350350903321
996   $aDevelopment of Novel Stability Indicating Methods Using Liquid Chromatography$91994017
997   $aUNINA